NewsKaustubh Bagalkote
First Trust Nasdaq Pharmaceuticals ETF
FTXH · ETF
$42.68−$0.5224 (−1.21%)TodayMarket closed ·
Prev close $43.20
Latest news
- NewsNabaparna Bhattacharya
What's Going On With Bristol-Myers Squibb Stock Today?
- NewsRishabh Mishra
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- NewsChandrima Sanyal
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs
- NewsRishabh Mishra
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
- NewsRishabh Mishra
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
- NewsRishabh Mishra
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
- NewsRishabh Mishra
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
- NewsRishabh Mishra
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
- NewsVandana Singh
Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations
- NewsChandrima Sanyal
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
- NewsMichael Juliano
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.